AzTrials
AzTrials

Delirium - PostoperativeNCT06879431

Preoperative Sleep Intervention on Postoperative Delirium in School-aged Children Undergoing Congenital Heart Surgery

A study testing cognitive-behavioral intervention in people with Delirium - Postoperative and Sleep Problems, run by Yan Fuxia at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This is a multicenter, randomized, controlled clinical trial aimed to determine whether preoperative sleep interventions could reduce the incidence of adverse outcomes, such as postoperative delirium, in sleep-disordered school-aged children undergoing congenital heart surgery. Read more about this study

Who is it for?
Ages 6 to 12 years
What is being tested?
cognitive-behavioral intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
544 participants
Where
1 siteChina
Study dates
28 Apr 2025to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age 0-36 months
  • Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.
  • Sleep disorder assessed by Children's Sleep Habits Questionnaire (CSHQ) (CSHQ score >48)

Who cannot join

  • Preoperative use of sleep therapy-related medications
  • The risk adjustment in congenital heart surgery-1 (RACHS-1 classification) ≥4
  • History of preoperative cardiac assist device, mechanical ventilation support, or asphyxia rescue
  • Emergency surgery or preoperative ICU admission
  • History of neurodevelopmental disorders such as autism spectrum disorder, attention deficit hyperactivity disorder, or psychiatric disorders such as depression
  • Combined severe hepatic and renal dysfunction
Show all 10Show fewer
  • Combination of non-cardiac malformations (adenoid hypertrophy, tracheobronchial stenosis, polysplenism, anaplastic syndrome, Down syndrome, DiGeoge syndrome, diabetes mellitus, reproductive system abnormalities, anal atresia and Williams syndrome, eye disorders)
  • History of preoperative cerebral ischemia and hypoxia
  • Concurrent participation in other clinical trials
  • Refusal of the family to sign the informed consent form or poor compliance by the child

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • Fuwai Hospital, Chinese Academy of Medical Sciences

    Beijing, 100037

    Fuxia Yan, +861088396628, yanfuxia@sina.com

    Recruiting

Other trials in China

About this study

Official title: The Impact of Cognitive Behavioral Intervention On Postoperative Delirium In School-aged Children With Sleep Disorder Undergoing Congenital Heart Surgery: A Multicenter, Randomized Controlled Clinical Trial

This is a multicenter, randomized, controlled clinical trial aimed to determine whether preoperative sleep interventions could reduce the incidence of adverse outcomes, such as postoperative delirium, in sleep-disordered school-aged children undergoing congenital heart surgery. The study will include infants and toddlers undergoing elective cardiac surgery with sleep disorders, assessed by the Children's Sleep Habits Questionnaire (CSHQ). All participants will be randomly assigned to the intervention group and Controll group in a 1:1 ratio. The intervention group received a short intensive cognitive-behavioral intervention 7-14 days before surgery, and no intervention was imposed on the control group. The results of this study will provide suggestions for the prevention of delirium after cardiac surgery.

Read the detailed description

The study will be carried out in Fuwai Hospital, Chinese Academy of Medical Sciences, Anzhen Hospital Affiliated to Capital Medical University, Fuwai Central China Cardiovascular Hospital, Fuwai Cardiovascular Hospital of Yunnan Province, and Children's Hospital Affiliated to Capital Institute of Pediatrics.

The research process is as follows: Conduct a routine assessment of sleep disorders for the children visiting the outpatient clinic. The guardians fill out the online Children's Sleep Habits Questionnaire. Fully inform the children with sleep disorders and their guardians of all the contents and procedures of this trial. After obtaining informed consent and signing the informed consent form, conduct a further assessment on the children to determine whether they meet the inclusion and exclusion criteria. All enrolled children and their guardians will receive preoperative education for congenital heart disease in the outpatient clinic. After stratification by research center, the random block is set to 4 - 6, the R will be used to randomly assign subjects to the experimental group and the control group at a 1:1 ratio. After randomization, the parents of children in the experimental group register for a WeChat mini-program, and the children receive cognitive-behavioral interventions every day before surgery. Guardians need to strictly implement and cooperate with researchers through phone calls (during the waiting period for admission) or face-to-face communication (during the preoperative hospitalization period). The control group does not receive any intervention and follows routine clinical practice. To better control the quality of interventions for children aged 6 - 12 in the experimental group, the daily implementation status of parents is counted for the degree of implementation (0 - 100%) in the WeChat mini-program. Guardians record the children's daily sleep diaries (online questionnaires) before surgery. The day before surgery, parents fill out the online Children's Sleep Habits Questionnaire again and compare the scores with the baseline scores. After admission, children wear actigraphs until the day of surgery and until discharge after surgery to automatically record sleep-related information. After the children are enrolled in the study, relevant researchers will supervise the implementation of cognitive-behavioral interventions for the children once a day before surgery to ensure that the actigraph device functions properly during hospitalization and remind guardians to record electronic sleep diaries until the night before surgery. Follow-up will be conducted within 7 days after surgery or before discharge to evaluate outcomes such as delirium and pain. The primary outcome is the incidence of postoperative delirium, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis.

Being tested
cognitive-behavioral intervention
Medical subject headings
Emergence Delirium, Parasomnias, Heart Defects, Congenital

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • cognitive-behavioral interventionBehavioural

    After enrollment in the experimental group, the guardians were asked to fill out a sleep diary every day before surgery to self-report the children's sleep, and to wear a somatic movement recorder to monitor sleep (non-dominant arm) (wGT3x-BT accelerometer, ActiGraph) during the preoperative hospitalization period, except during surgery, and then to wear it to record the sleep-related parameters until 7 days after surgery or before discharge from the hospital.Preoperative daily cognitive-behavioral interventions (developmental trials were guided with WeChat applets), including cognitive change, sleep hygiene, sleep restriction, stimulus control, and relaxation training

Study groups in NCT06879431
Study groupRoleWhat they receive
CBT groupExperimentalThe intervention group received a short intensive cognitive-behavioral therapy (CBT) intervention 7-14 days before surgery
Receives: Behavioral: cognitive-behavioral intervention
control groupNo interventionno intervention was imposed on the control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of postoperative delirium

    Measured: Postoperative 7 days

Secondary outcomes (20)
  1. Mechanistic endpoint: Concentration of plasma S-100β protein

    S-100β protein was used as a surrogate biomarker for the disruption of the blood-brain barrier.

    Measured: Before surgery, at the end of surgery and 24 hours after surgery

  2. Pain defined by the Wong-Baker faces pain scale (revision)

    The Faces Pain Scale-Revised (FPS-R) requires patients to rate their overall pain intensity on a scale from 0 (no pain) to 10 (worst possible pain). Simultaneously, the FPS-R provides six cartoon illustrations of facial expressions (ranging from smiling, sad, to agonized crying) to visually represent the pain levels corresponding to different score ranges. This design aligns with children's concrete thinking characteristics. During assessment, the child simply points to the numerical rating or cartoon face that best matches their perceived pain intensity, making it particularly suitable for children aged 4 to 12 years.

    Measured: Postoperative 7 days

  3. The incidence of postoperative Acute kidney injury

    Measured: Within postoperative 7 days

  4. The incidence of Pulmonary complication

    Measured: Postoperative 7 days

  5. The incidence of postoperative Liver dysfunction

    Measured: Postoperative 7 days

  6. Concentration of intestinal fatty acid binding protein (I-FABP)

    one of markers of intestinal injury

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  7. Concentration of zonulin

    One of markers of intestinal injury

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  8. Concentration of lipopolysaccharide (LPS)

    one of markers of intestinal injury

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  9. Concentration of lipopolysaccharide binding protein (LBP)

    One of markers of intestinal injury

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  10. Types and dosages of drugs used for postoperative sedation and analgesia

    Measured: Postoperative 7 days or before discharge

  11. Concentration of IL-6

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  12. Concentration of TNF-α

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  13. Concentration of IL-1β

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  14. Concentration of IFN-γ

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  15. Concentration of IL-17

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  16. Concentration of C-reactive protein

    Measured: before surgery, at the end of surgery and 24 hours after surgery

  17. The duration of postoperative mechanical ventilation

    Measured: From the end of the surgery to the removal of the tracheal intubation,up to 30days

  18. The length of intensive care unit stay

    The time spent in the intensive care unit.

    Measured: From the end of the surgery to discharge from the hospital,up to 30 days

  19. The length of postoperative hospital stay

    Measured: From the end of the surgery to the day of discharge from the hospital,up to 30 days

  20. Average daily cost

    total hospitalization cost divided by total length of stay

    Measured: admission to discharge, up to 30days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2025
  2. Study start28 Apr 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
544 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06879431
Sponsor's protocol ID
2025-2602
Status last verified
Mar 2025
First submitted
25 Feb 2025
Last updated
31 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing cognitive-behavioral intervention in people with Delirium - Postoperative and Sleep Problems, run by Yan Fuxia at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 31 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fuxia Yan (010 88396628, yanfuxia@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of postoperative delirium (time frame: Postoperative 7 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in